EVERSANA is excited to join Canadian and international health technology experts at Symposium 2024.
EVERSANA’s 2024 Poster Presentations
- Recent Trends in Oncology Submissions to CDA-AMC Supported by Single-arm Trials
Yixie Zhang, Sumeet Singh
DOWNLOAD NOW - Characterizing Files Reviewed Through the CDA-AMC Complex Review Process: 2020-2023
Sydney Jopling, Kamalpreet Mann, Christine Malmberg, Raveen Muzaffar
DOWNLOAD NOW - A Cross-sectional Assessment of the Relative Timing of CDA-AMC and INESSS Sponsor-submitted Reimbursement Reviews and pCPA Engagement
Sydney Whitney, Aidan Dineen
DOWNLOAD NOW - CDA-AMC ‘Do Not Reimburse’ Oncology Recommendations from 2019-2024:
Trends and Submission Characteristics
Sumeet Singh
DOWNLOAD NOW
EVERSANA’S Latest Market Access Insights
Meet us at to learn more or CDA_AMCschedule a time to meet our experts.